← Back to headlines
Immatics and Four Other Companies Face Increased Activist Investor Pressure
Several publicly traded firms, including biotech developer Immatics, are experiencing heightened engagement from activist shareholders pushing for strategic or operational changes.
4 Sept, 22:59 — 4 Sept, 22:59
Sources
Showing 1 of 1 sources
